Sernova Corp. Release: Dr. George Adams Appointed To Board Of Directors To Help Commercialize Insulin Dependent Diabetes Product

KELOWNA, BRITISH COLUMBIA -- (MARKET WIRE) -- September 25, 2006 -- Sernova Corp. ("Sernova") (TSX VENTURE: SVA) is pleased to announce that Dr. George Adams of Toronto, Ontario has been appointed to the Board of Directors to assist Sernova in moving its diabetes product development to the commercialization stage.
MORE ON THIS TOPIC